Edwards Lifesciences Corporation
EW · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $45 | $46 | $43 | $44 |
| - Cash | $3 | $3 | $3 | $3 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $43 | $43 | $40 | $41 |
| Revenue | $2 | $2 | $1 | $1 |
| % Growth | 1.4% | 8.5% | 1.9% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 77.9% | 77.6% | 78.7% | 78.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25% | 26.1% | 33.3% | 34.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 18.7% | 21.5% | 25.3% | 27.8% |
| EPS Diluted | 0.5 | 0.56 | 0.61 | 0.65 |
| % Growth | -10.7% | -8.2% | -6.2% | – |
| Operating Cash Flow | $1 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | -$0 |